GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?
- PMID: 23276773
- DOI: 10.1016/j.diagmicrobio.2012.11.011
GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?
Abstract
We performed a retrospective analysis of costs and time to treatment (TT) of 150 culture-confirmed TB cases: 100 sputum smear (SS) (+) and 50 SS(-). This group underwent GeneXpert® (GX) assay. Expenditures and TT of SS(-)/GX(+) cases were inferred from the SS(+) group. GX detected 68% of SS(-) cases.
Copyright © 2013 Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources